Skip to main content

System for AcceleroMeter-Based Assessment of cardiac FUNction

Objective

In patients undergoing open-heart surgeries, perioperative cardiac monitoring is used to track the functioning of the heart and identify complications. However, myocardial failure and other severe complications can escape detection using current monitoring technologies, given the trade-offs between invasiveness, real time measurements, accessibility and accuracy of data. Given the high-risk profile of these surgeries, failure to timely detect complications leads to increased mortality and morbidity, which in turn results in increased hospitalization costs and lower quality of life for the affected patients.

For effective cardiac monitoring, surgeons need real time data, 24h continuous monitoring during and post-surgery, and an accurate biosignal marker that can be trusted for immediate detection and assessment of cardiac events. No current technology enables this with low invasiveness and risk.

Cardiaccs (SME) and Osypka (SME) will bring to market a patented solution that involves adding a 3-axis accelerometer to a standard epicardial pace lead, which is routinely used for most cardiac surgical patients, to assess cardiac motion and contractility in real time, both during and after surgery – and up to 7 days. Data from CardiSense will appear on a monitor and an alert function will let surgeons and nurses know as soon as a complication is picked-up on the continuously analysed data.

SAMBAfun brings together 2 SMEs with complementary know-how, IPR and value chain positions. Cardiaccs patented the concept, whereas Osypka has 40 years of experience in developing cardiac pace leads. Osypka dominates the German market and has extensive ties to global distributors. Three leading research hospitals (Oslo, Aarhus and Berlin) will demonstrate the latest advances in this device, provide Key Opinion Leader input and contribute with multi-market, highly credible data for regulatory certification and health economic models to support reimbursement applications in all markets.

Call for proposal

H2020-EIC-FTI-2018-2020
See other projects for this call

Coordinator

CARDIACCS AS
Address
Maridalsveien 71B
0458 Oslo
Norway
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 1 107 221,50

Participants (4)

OSYPKA AG
Germany
EU contribution
€ 690 375
Address
Earl H Wood Strasse 1
79618 Rheinfelden Baden
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
OSLO UNIVERSITETSSYKEHUS HF
Norway
EU contribution
€ 454 903,75
Address
Kirkeveien 166 Tarnbygget
0450 Oslo
Activity type
Higher or Secondary Education Establishments
AARHUS UNIVERSITET
Denmark
EU contribution
€ 487 312,50
Address
Nordre Ringgade 1
8000 Aarhus C
Activity type
Higher or Secondary Education Establishments
DEUTSCHES HERZZENTRUM BERLIN
Germany
EU contribution
€ 178 500
Address
Augustenburger Platz 1
13353 Berlin
Activity type
Higher or Secondary Education Establishments